IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: contrarian who wrote (1497)	3/4/1998 12:09:00 PM
From: AJAG	Read Replies (1) of 1762

Hey guys! Forget pure technical analysis when it comes to biotechs- Here is the REAL REASON that IDEC is going to go up- Lehman Brothers reports that sales of their lead product so far are at the high end of expectations and have raised their earnings estimate from 26 cents to fifty cents, and target price of the stock to 59 dollars. You can take a look for yourself- just find the Lehman Brothers biotechnology web site. Lehman reports "significant off label use" of Rituxan.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next